Index S&P 500
P/E 21.89
EPS (ttm) 3.32
Insider Own 1.43%
Shs Outstand 231.72M
Perf Week 1.69%
Market Cap 16.49B
Forward P/E 15.49
EPS next Y 4.69
Insider Trans -4.12%
Shs Float 223.70M
Perf Month -8.84%
Income 789.50M
PEG 2.19
EPS next Q 1.01
Inst Own 103.51%
Short Float 2.31%
Perf Quarter -9.26%
Sales 4.03B
P/S 4.09
EPS this Y 4.68%
Inst Trans 2.41%
Short Ratio 2.77
Perf Half Y -2.06%
Book/sh 22.14
P/B 3.28
EPS next Y 9.84%
ROA 8.63%
Short Interest 5.18M
Perf Year 2.21%
Cash/sh 10.28
P/C 7.07
EPS next 5Y 10.00%
ROE 15.56%
52W Range 70.36 - 84.67
Perf YTD 1.72%
Dividend Est. -
P/FCF 14.28
EPS past 5Y -
ROI 10.22%
52W High -14.16%
Beta 0.97
Dividend TTM -
Quick Ratio 3.03
Sales past 5Y 6.10%
Gross Margin 55.53%
52W Low 3.30%
ATR (14) 1.54
Dividend Ex-Date -
Current Ratio 3.69
EPS Y/Y TTM 81.34%
Oper. Margin 24.07%
RSI (14) 36.20
Volatility 1.89% 2.19%
Employees 7063
Debt/Eq 0.52
Sales Y/Y TTM -0.00%
Profit Margin 19.59%
Recom 2.33
Target Price 87.62
Option/Short Yes / Yes
LT Debt/Eq 0.51
EPS Q/Q 106.46%
Payout 0.00%
Rel Volume 0.37
Prev Close 72.68
Sales Surprise 0.99%
EPS Surprise -0.32%
Sales Q/Q 4.51%
Earnings Nov 04 AMC
Avg Volume 1.87M
Price 72.68
SMA20 -2.90%
SMA50 -6.81%
SMA200 -6.45%
Trades
Volume 194,909
Change 0.00%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-13-24 Initiated
Wolfe Research
Peer Perform
Dec-10-24 Reiterated
Needham
Buy
$90
Dec-10-24 Initiated
Jefferies
Hold
$85
Oct-01-24 Downgrade
Citigroup
Buy → Neutral
$95 → $85
Jun-27-24 Initiated
Stephens
Overweight
$87
Apr-03-24 Upgrade
Citigroup
Neutral → Buy
$80 → $95
Jul-14-23 Upgrade
Needham
Hold → Buy
$95
Dec-07-22 Initiated
RBC Capital Mkts
Sector Perform
$75
Oct-13-22 Initiated
Mizuho
Buy
$75
Jul-20-22 Initiated
UBS
Neutral
$73
Jul-20-22 Downgrade
BofA Securities
Buy → Neutral
$81 → $75
Jul-18-22 Downgrade
BTIG Research
Buy → Neutral
Apr-25-22 Downgrade
Wells Fargo
Overweight → Equal Weight
$75
Apr-04-22 Downgrade
Evercore ISI
Outperform → In-line
$80
Dec-15-21 Downgrade
Citigroup
Buy → Neutral
$85 → $78
Oct-15-21 Resumed
Cowen
Outperform
$83
Oct-14-21 Initiated
Redburn
Neutral
Jul-06-21 Upgrade
Evercore ISI
In-line → Outperform
$78
Nov-20-20 Downgrade
Needham
Buy → Hold
Nov-05-20 Reiterated
Needham
Buy
$78 → $88
Show Previous Ratings
Dec-24-24 09:00AM
Dec-23-24 12:19PM
Dec-19-24 05:45PM
06:45AM
Dec-18-24 08:08AM
06:50AM
Loading…
Dec-14-24 06:50AM
Dec-13-24 07:10PM
05:45PM
09:00AM
Dec-10-24 11:10PM
04:01PM
Dec-09-24 04:05PM
08:05AM
Dec-04-24 11:30AM
Dec-02-24 01:29PM
08:08AM
Loading…
08:08AM
Nov-25-24 08:22AM
Nov-19-24 09:00AM
Nov-14-24 08:08AM
Nov-08-24 12:21PM
09:00AM
Nov-05-24 11:43AM
(Morningstar Research) -5.88%
06:35AM
(Thomson Reuters StreetEvents)
02:06AM
Nov-04-24 05:30PM
05:15PM
04:20PM
(Associated Press Finance)
04:01PM
Oct-30-24 09:15AM
Oct-28-24 05:45PM
10:01AM
Loading…
10:01AM
06:18AM
Oct-25-24 02:57PM
Oct-23-24 09:00AM
06:00AM
Oct-21-24 05:45PM
Oct-15-24 05:45PM
08:05AM
07:32AM
07:02AM
Oct-14-24 02:07PM
08:05AM
Oct-11-24 09:00AM
Oct-09-24 12:10PM
Oct-08-24 05:45PM
Oct-04-24 08:22AM
Oct-02-24 05:45PM
Oct-01-24 09:36AM
Sep-30-24 09:17AM
09:00AM
Sep-26-24 05:45PM
Sep-24-24 09:40AM
Sep-20-24 05:45PM
Sep-17-24 09:00AM
Sep-11-24 09:50AM
Sep-06-24 09:00AM
Sep-02-24 09:40AM
Aug-29-24 08:08AM
Aug-28-24 11:30AM
Aug-26-24 09:00AM
Aug-20-24 08:01AM
Aug-13-24 09:00AM
Aug-09-24 08:20AM
06:51AM
Aug-05-24 09:15AM
Aug-02-24 09:00AM
Aug-01-24 04:40PM
Jul-31-24 09:30AM
Jul-30-24 01:04PM
11:20AM
(Thomson Reuters StreetEvents)
08:22AM
08:08AM
04:32AM
Jul-29-24 07:22PM
05:30PM
05:15PM
04:10PM
(Associated Press Finance)
04:01PM
Jul-26-24 11:52AM
05:12AM
Jul-25-24 09:15AM
08:19AM
Jul-22-24 05:45PM
Jul-19-24 08:55AM
Jul-17-24 09:10AM
Jul-16-24 05:45PM
09:00AM
Jul-09-24 04:05AM
Jul-08-24 05:45PM
Jul-04-24 08:35AM
Jul-02-24 08:22AM
Jun-27-24 10:25AM
Jun-25-24 05:45PM
09:30AM
Jun-24-24 09:00AM
Jun-11-24 09:00AM
Jun-04-24 12:08PM
May-31-24 09:00AM
May-29-24 09:30AM
May-23-24 08:53AM
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products, that focuses on women's health and well-being through early detection and treatment. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment is involved in a portfolio of solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology and treatment. The Diagnostics segment offers a range of products, which are used primarily to aid in the screening and diagnosis of human diseases. The GYN Surgical segment is involved in hysteroscopic endometrial ablation systems, tissue removal systems, fluid management systems, and laparoscopic tissue ablation systems and tools. The Skeletal Health segment covers the Horizon DXA and the Fluoroscan Insight FD mini C-arm. The company was founded by S. David Ellenbogen and Jay A. Stein in 1985 and is headquartered in Marlborough, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Mitchell Essex D Chief Operating Officer Dec 04 '24 Option Exercise 62.60 22,902 1,433,659 52,813 Dec 06 04:28 PM Mitchell Essex D Chief Operating Officer Dec 04 '24 Sale 76.34 24,856 1,897,482 27,957 Dec 06 04:28 PM Mitchell Essex D Officer Dec 04 '24 Proposed Sale 76.34 24,856 1,897,484 Dec 04 12:24 PM Oberton Karleen Marie Chief Financial Officer Aug 29 '24 Option Exercise 40.95 32,805 1,343,214 136,721 Sep 03 04:15 PM Oberton Karleen Marie Chief Financial Officer Aug 29 '24 Sale 80.56 52,679 4,243,662 84,042 Sep 03 04:15 PM Oberton Karleen Marie Officer Aug 29 '24 Proposed Sale 80.56 52,679 4,243,657 Aug 29 04:36 PM Schnittker Brandon Div. President, GYN Surgical Aug 06 '24 Sale 83.11 476 39,559 3,735 Aug 08 04:08 PM Schnittker Brandon Officer Aug 06 '24 Proposed Sale 83.11 476 39,559 Aug 06 04:48 PM COHN BENJAMIN JORDAN Principal Accounting Officer Aug 01 '24 Sale 81.99 5,093 417,570 10,476 Aug 05 04:29 PM MACMILLAN STEPHEN P Chairman, President and CEO Jul 30 '24 Option Exercise 26.21 44,039 1,154,262 1,201,601 Aug 01 04:09 PM MACMILLAN STEPHEN P Chairman, President and CEO Jul 30 '24 Sale 81.70 44,039 3,597,924 1,157,562 Aug 01 04:09 PM COHN BENJAMIN JORDAN Officer Aug 01 '24 Proposed Sale 81.99 5,093 417,574 Aug 01 03:58 PM MACMILLAN STEPHEN P Officer Jul 30 '24 Proposed Sale 81.70 44,039 3,597,894 Jul 30 04:29 PM MACMILLAN STEPHEN P Chairman, President and CEO Jul 17 '24 Option Exercise 26.21 3,672 96,243 1,161,234 Jul 19 04:09 PM MACMILLAN STEPHEN P Chairman, President and CEO Jul 17 '24 Sale 80.13 3,672 294,223 1,157,562 Jul 19 04:09 PM Stamoulis Christiana Director Jul 17 '24 Option Exercise 26.74 9,039 241,703 54,511 Jul 19 04:06 PM Stamoulis Christiana Director Jul 17 '24 Sale 79.50 9,039 718,600 45,472 Jul 19 04:06 PM GARRETT SCOTT T Director Mar 14 '24 Option Exercise 30.93 16,441 508,471 65,052 Mar 15 04:11 PM GARRETT SCOTT T Director Mar 14 '24 Sale 75.50 16,441 1,241,296 48,611 Mar 15 04:11 PM Dockendorff Charles J Director Mar 08 '24 Sale 76.21 1,465 111,648 1,572 Mar 11 06:45 PM CRAWFORD SALLY Director Mar 08 '24 Option Exercise 26.74 9,039 241,703 141,966 Mar 11 06:41 PM CRAWFORD SALLY Director Mar 08 '24 Sale 76.40 9,039 690,607 132,927 Mar 11 06:41 PM Oberton Karleen Marie Chief Financial Officer Jan 29 '24 Sale 75.00 14,940 1,120,500 103,916 Jan 30 04:08 PM Dockendorff Charles J Director Jan 02 '24 Option Exercise 38.44 7,551 290,260 17,482 Jan 04 04:09 PM Dockendorff Charles J Director Jan 02 '24 Sale 72.00 16,017 1,153,224 1,465 Jan 04 04:09 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite